Veerhealth Care share news, announcements and annual reports
BSE: 511523Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹49.17.
28 Oct: open ₹49.50, high ₹49.50, low ₹48.31
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹98 Cr3,569th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 63.88
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.31 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 53.12
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.26
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.31 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 8.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,13,386
Veerhealth Care share news and announcements
543 announcements, routine notices left out, newest first. Page 4 of 11.
May 2024
21 May · Board meeting
Meeting on 30 May 2024: audited results and final dividend
Apr 2024
10 Apr · Compliances-Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015
3 Apr · Compliances-Compliance Certificate For The Period Ended March 31, 2024
1 Apr · Business
1 Apr · Announcement under Regulation 30 (LODR)-Retirement
Mar 2024
29 Mar · Analysts
Feb 2024
21 Feb · Announcement Under Regulation 30 (LODR) - Additional Details Pursuant To SEBI Circular Dated July 13, 2023 And Regulation 30 Of SEBI (LODR) Regulations, 2015
15 Feb · Board meeting
Meeting on 20 Feb 2024: rights issue of equity shares10 Feb · Announcement Under Regulation 30 (LODR) - Reconstitution Of Committees
2 Feb · Board meeting
Meeting on 10 Feb 2024: quarterly results
Jan 2024
29 Jan · Announcement Under Regulation 30 (LODR) - Allotment Of Labeler Code By United States (US) FDA
12 Jan · Announcement Under Regulation 30 (LODR) - Successful Registration Of Products On Government E-Marketplace (Gem) Portal
Nov 2023
8 Nov · Board meeting
Oct 2023
30 Oct · Board meeting
Meeting on 8 Nov 2023: quarterly results
Sep 2023
25 Sep · Board meeting
Meeting on 25 Sep 2023
Aug 2023
31 Aug · Announcement Under Regulation 30 (LODR) - Updates - Termination Of MOU
29 Aug · Announcement Under Regulation 30 (LODR) - Updates: Company Signed MOU With M/S. ONEST LIMITED For Manufacturing And Supply Of Oral Care Range Of Prodcuts
17 Aug · Announcement Under Regulation 30 (LODR) - Additional Details For Corporate Announcement Filed Dated 14Th August, 2023
14 Aug · Management